Targeting the folate receptor: diagnostic and therapeutic approaches to personalize cancer treatments.
about
Targeting folate receptor alpha for cancer treatmentProfile of farletuzumab and its potential in the treatment of solid tumorsPrecision targeted therapy of ovarian cancerPotent Therapeutic Activity Against Peritoneal Dissemination and Malignant Ascites by the Novel Anti-Folate Receptor Alpha Antibody KHK2805.Exploiting the co-reliance of tumours upon transport of amino acids and lactate: Gln and Tyr conjugates of MCT1 inhibitorsMirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, Potentiates the Activity of Standard of Care Therapeutics in Ovarian Cancer ModelsNew Approaches for Immune Directed Treatment for Ovarian Cancer.Folate receptor alpha antagonists in preclinical and early stage clinical development for the treatment of epithelial ovarian cancer.Folate-mediated chemotherapy and diagnostics: An updated review and outlook.Folate Receptor-Positive Gynecological Cancer Cells: In Vitro and In Vivo Characterization.Folate-PEG Conjugates of a Far-Red Light-Activatable Paclitaxel Prodrug to Improve Selectivity toward Folate Receptor-Positive Cancer Cells.Light induced drug release from a folic acid-drug conjugate.Safety and Activity of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: A Phase I Expansion Study.Synthesis of Size-Tunable Hollow Polypyrrole Nanostructures and Their Assembly into Folate-Targeting and pH-Responsive Anticancer Drug-Delivery Agents.A review of mirvetuximab soravtansine in the treatment of platinum-resistant ovarian cancer.Improved Intraoperative Detection of Ovarian Cancer by Folate Receptor Alpha Targeted Dual-Modality Imaging.Advances in ovarian cancer therapy.Phase 1 dose-escalation study of mirvetuximab soravtansine (IMGN853), a folate receptor α-targeting antibody-drug conjugate, in patients with solid tumors.Assessment of folate receptor alpha and beta expression in selection of lung and pancreatic cancer patients for receptor targeted therapies.In vitro and in vivo activity of IMGN853, an Antibody-Drug Conjugate targeting Folate Receptor Alpha linked to DM4, in biologically aggressive endometrial cancers.Transcriptional control of the MUC16 promoter facilitates follicle-stimulating hormone peptide-conjugated shRNA nanoparticle-mediated inhibition of ovarian carcinoma in vivo.A paclitaxel prodrug with bifunctional folate and albumin binding moieties for both passive and active targeted cancer therapy.Contrasting roles for actin in the cellular uptake of cell penetrating peptide conjugates.Advances in targeting the folate receptor in the treatment/imaging of cancers.Leveraging PET to image folate receptor α therapy of an antibody-drug conjugateEarly Investigations and Recent Advances in Intraperitoneal Immunotherapy for Peritoneal MetastasisOne-Carbon Metabolism: Biological Players in Epithelial Ovarian Cancer
P2860
Q26744215-8FE0E08E-2B14-49F5-B2CD-9E017431F827Q26750431-7AE71743-E4E1-4E8D-A891-201D75CB398CQ28078658-918F55CD-FD1A-41D7-BF31-6C25EBCA58EAQ33900573-08E4D4D3-0B9B-4E9E-A61A-EB93D7DC7765Q37029221-72F4F2F7-A8EE-423A-BD66-D39C3A9A0DC1Q37447340-FC44D9C5-8304-4790-B9E7-EE3803E3FCFCQ38760516-6080C372-4679-4281-AE82-BC4701EBB4CCQ38995020-58856E79-D4C3-42A5-8146-6AAF85B8F00EQ39149880-531489AF-CCBD-4EC2-A691-AA2453F94262Q42366884-DDEDCADC-D51B-4A5F-8823-2C9AFFF45A68Q44583167-108F7CB4-A112-4C13-AD8F-2FEAAC912D34Q45049944-7E1A0C9E-52CB-4B1D-9D57-0B3AE6E0380BQ46871150-B7CD438C-FEF1-4CA4-AB2A-65B55FC10B36Q47187777-69782293-5440-4A0A-9684-6E8C7A064401Q47861842-3700C631-48E5-4CA8-8F2A-C7F6441EDFEEQ47926770-0C85D70E-FDC0-4918-8B85-0CE975B165F6Q48104995-F9BB8FCC-F149-413E-AEB0-65FF50B08817Q48234647-7F2CA411-E1EA-4EFE-B4E6-0F73AE584A29Q49750232-81816590-829E-4057-A058-0D9C97B08C42Q50027073-E175B65A-8DE3-40E4-8296-3FA302787F2CQ52354783-59AAEC0E-6B50-4E97-AEAA-F70FC3035693Q54958677-C9A9ABC6-A185-4E91-A873-0958C2414EF2Q54991036-A505CD08-61EA-4CB0-9A45-3E761F2F24A0Q55315165-6BD8945D-A63E-4AB5-97E7-F3553DA3F690Q58699756-A3A042AE-CD04-4A07-9463-B23A1245803EQ58788761-AABEB483-05B5-4285-BCFE-828F14D40C0CQ59134002-C916DC5A-1BF5-48F0-B376-5CF47808DC93
P2860
Targeting the folate receptor: diagnostic and therapeutic approaches to personalize cancer treatments.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Targeting the folate receptor: ...... personalize cancer treatments.
@en
type
label
Targeting the folate receptor: ...... personalize cancer treatments.
@en
prefLabel
Targeting the folate receptor: ...... personalize cancer treatments.
@en
P2093
P2860
P356
P1433
P1476
Targeting the folate receptor: ...... personalize cancer treatments.
@en
P2093
J A Ledermann
S Canevari
P2860
P304
P356
10.1093/ANNONC/MDV250
P577
2015-06-10T00:00:00Z